ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4

M. Pieraccioli, S. Nicolai, A. Antonov, J. Somers, M. Malewicz, G. Melino, G. Raschellà

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

ZNF281 is a zinc-finger factor involved in the control of cellular stemness and epithelial–mesenchymal transition (EMT). Here, we report that ZNF281 expression increased after genotoxic stress caused by DNA-damaging drugs. Comet assays demonstrated that DNA repair was delayed in cells silenced for the expression of ZNF281 and treated with etoposide. Furthermore, the expression of 10 DNA damage response genes was downregulated in cells treated with etoposide and silenced for ZNF281. In line with this finding, XRCC2 and XRCC4, two genes that take part in homologous recombination and non-homologous end joining, respectively, were transcriptionally activated by ZNF281 through a DNA-binding-dependent mechanism, as demonstrated by luciferase assays and Chromatin crosslinking ImmunoPrecipitation experiments. c-Myc, which also binds to the promoters of XRCC2 and XRCC4, was unable to promote their transcription or to modify ZNF281 activity. Of interest, bioinformatic analysis of 1971 breast cancer patients disclosed a significant correlation between the expression of ZNF281 and that of XRCC2. In summary, our data highlight, for the first time, the involvement of ZNF281 in the cellular response to genotoxic stress through the control exercised on the expression of genes that act in different repair mechanisms.Oncogene advance online publication, 24 August 2015; doi:10.1038/onc.2015.320.

Original languageEnglish
JournalOncogene
DOIs
Publication statusAccepted/In press - Aug 24 2015

Fingerprint

DNA Damage
Etoposide
Comet Assay
Chromatin Immunoprecipitation
Homologous Recombination
DNA
Zinc Fingers
Computational Biology
Luciferases
Oncogenes
DNA Repair
Genes
Publications
Down-Regulation
Breast Neoplasms
Gene Expression
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Pieraccioli, M., Nicolai, S., Antonov, A., Somers, J., Malewicz, M., Melino, G., & Raschellà, G. (Accepted/In press). ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4. Oncogene. https://doi.org/10.1038/onc.2015.320

ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4. / Pieraccioli, M.; Nicolai, S.; Antonov, A.; Somers, J.; Malewicz, M.; Melino, G.; Raschellà, G.

In: Oncogene, 24.08.2015.

Research output: Contribution to journalArticle

Pieraccioli, M. ; Nicolai, S. ; Antonov, A. ; Somers, J. ; Malewicz, M. ; Melino, G. ; Raschellà, G. / ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4. In: Oncogene. 2015.
@article{f90d61383b3a44779816820d03dea847,
title = "ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4",
abstract = "ZNF281 is a zinc-finger factor involved in the control of cellular stemness and epithelial–mesenchymal transition (EMT). Here, we report that ZNF281 expression increased after genotoxic stress caused by DNA-damaging drugs. Comet assays demonstrated that DNA repair was delayed in cells silenced for the expression of ZNF281 and treated with etoposide. Furthermore, the expression of 10 DNA damage response genes was downregulated in cells treated with etoposide and silenced for ZNF281. In line with this finding, XRCC2 and XRCC4, two genes that take part in homologous recombination and non-homologous end joining, respectively, were transcriptionally activated by ZNF281 through a DNA-binding-dependent mechanism, as demonstrated by luciferase assays and Chromatin crosslinking ImmunoPrecipitation experiments. c-Myc, which also binds to the promoters of XRCC2 and XRCC4, was unable to promote their transcription or to modify ZNF281 activity. Of interest, bioinformatic analysis of 1971 breast cancer patients disclosed a significant correlation between the expression of ZNF281 and that of XRCC2. In summary, our data highlight, for the first time, the involvement of ZNF281 in the cellular response to genotoxic stress through the control exercised on the expression of genes that act in different repair mechanisms.Oncogene advance online publication, 24 August 2015; doi:10.1038/onc.2015.320.",
author = "M. Pieraccioli and S. Nicolai and A. Antonov and J. Somers and M. Malewicz and G. Melino and G. Raschell{\`a}",
year = "2015",
month = "8",
day = "24",
doi = "10.1038/onc.2015.320",
language = "English",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4

AU - Pieraccioli, M.

AU - Nicolai, S.

AU - Antonov, A.

AU - Somers, J.

AU - Malewicz, M.

AU - Melino, G.

AU - Raschellà, G.

PY - 2015/8/24

Y1 - 2015/8/24

N2 - ZNF281 is a zinc-finger factor involved in the control of cellular stemness and epithelial–mesenchymal transition (EMT). Here, we report that ZNF281 expression increased after genotoxic stress caused by DNA-damaging drugs. Comet assays demonstrated that DNA repair was delayed in cells silenced for the expression of ZNF281 and treated with etoposide. Furthermore, the expression of 10 DNA damage response genes was downregulated in cells treated with etoposide and silenced for ZNF281. In line with this finding, XRCC2 and XRCC4, two genes that take part in homologous recombination and non-homologous end joining, respectively, were transcriptionally activated by ZNF281 through a DNA-binding-dependent mechanism, as demonstrated by luciferase assays and Chromatin crosslinking ImmunoPrecipitation experiments. c-Myc, which also binds to the promoters of XRCC2 and XRCC4, was unable to promote their transcription or to modify ZNF281 activity. Of interest, bioinformatic analysis of 1971 breast cancer patients disclosed a significant correlation between the expression of ZNF281 and that of XRCC2. In summary, our data highlight, for the first time, the involvement of ZNF281 in the cellular response to genotoxic stress through the control exercised on the expression of genes that act in different repair mechanisms.Oncogene advance online publication, 24 August 2015; doi:10.1038/onc.2015.320.

AB - ZNF281 is a zinc-finger factor involved in the control of cellular stemness and epithelial–mesenchymal transition (EMT). Here, we report that ZNF281 expression increased after genotoxic stress caused by DNA-damaging drugs. Comet assays demonstrated that DNA repair was delayed in cells silenced for the expression of ZNF281 and treated with etoposide. Furthermore, the expression of 10 DNA damage response genes was downregulated in cells treated with etoposide and silenced for ZNF281. In line with this finding, XRCC2 and XRCC4, two genes that take part in homologous recombination and non-homologous end joining, respectively, were transcriptionally activated by ZNF281 through a DNA-binding-dependent mechanism, as demonstrated by luciferase assays and Chromatin crosslinking ImmunoPrecipitation experiments. c-Myc, which also binds to the promoters of XRCC2 and XRCC4, was unable to promote their transcription or to modify ZNF281 activity. Of interest, bioinformatic analysis of 1971 breast cancer patients disclosed a significant correlation between the expression of ZNF281 and that of XRCC2. In summary, our data highlight, for the first time, the involvement of ZNF281 in the cellular response to genotoxic stress through the control exercised on the expression of genes that act in different repair mechanisms.Oncogene advance online publication, 24 August 2015; doi:10.1038/onc.2015.320.

UR - http://www.scopus.com/inward/record.url?scp=84940068669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940068669&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.320

DO - 10.1038/onc.2015.320

M3 - Article

AN - SCOPUS:84940068669

JO - Oncogene

JF - Oncogene

SN - 0950-9232

ER -